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Abstract: Fanconi Anemia (FA) is a syndrome associated with chromosomal fragility. 
Current laboratory tests to diagnose this disease are based on the scoring of chromosomal 
aberrations induced in peripheral blood lymphocytes by clastogenic chemical agents, 
mainly: diepoxybutane (DEB) or mitomycin C (MMC). This study evaluated an alternative 
test for the diagnosis of FA, in which ionizing radiation replaces DEB/MMC. Two groups 
were studied: normal and DEB-sensitive individuals. From each individual, samples of 
peripheral blood were irradiated using an electron linear accelerator. Following lymphocyte 
cultures, and slide preparation, metaphases were scored based on the same methodology 
for biological dosimetry, according to recommendations of the International Atomic Energy 
Agency. Our results emphasized a pattern of distribution of dicentrics, fragments, as well 
as abnormal chromosomal arrangements. The methodology of analysis here proposed 
permitted to distinguish normal from DEB-sensitive subjects.
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1 INTRODUCTION
Fanconi Anemia (FA) was firstly described by Guido Fanconi in 1927, after clinical 
observation of 3 brothers who presented aplastic anemia and similar clinical signs, such as 
hyperpigmentation and physical abnormalities.1 Primarily described as a rare autosomal 
recessive disease due to an increased incidence in families with blood ties, studies involving 
similar cases in families that had no inbreeding revealed an FA subtype, which is X-linked 
recessive. The overall prevalence of FA is around 1:100,000 for homozygous, and the 
average life expectancy is about 20 years.2-4 
Clinical manifestations of FA include small stature, congenital malformations, skin 
hyperpigmentation, pancytopenia, predisposition to neoplasia, and cancer, especially 
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hematological malignancies and solid tumors of the head and neck. The myriad of 
phenotypes involved in FA implies that the diagnosis of this disease, based only on clinical 
features, is not straightforward and is often dubious. At the cellular level, FA individuals 
present severe chromosomal fragility, with spontaneous chromosomal aberrations, 
characterized by failures in the system to repair of DNA interstrand crosslinks, which 
confers hypersensitivity to clastogenic agents. As a result, besides clinical signs, laboratory 
tests are employed for diagnostic purposes of Fanconi Anemia. 
The current routine laboratory tests commonly use toxic chemical agents to induce 
chromosomal aberrations in peripheral blood lymphocytes, such as diepoxybutane (DEB) 
or mitomycin C (MMC), which induces much more chromosomal alterations and breaks in 
FA cells than in cells from non-FA individuals.4 
On the other hand, ionizing radiation (IR) is a DNA-damaging physical agent, and 
studies have been evaluating the effects of IR on peripheral blood lymphocytes of Fanconi-
positive patients, with results either inconclusive or needing further improvements.5-9 
The process of irradiation directly influences the types and frequencies of chromosomal 
aberrations (CA), such as the type of irradiation source, dose, and dose-rates. Thus, the 
comparison of those researches is not straightforward since they generally employ 
different irradiation strategies. 
The frequency of CA in circulating lymphocytes of human blood is the most 
extensively studied bioindicator of individual exposure to ionizing radiation.10-12 The 
methodology so-called biological dosimetry is applied in the investigation of induced 
biological endpoints to correlate them with radiation dose.13,14 The scoring of chromosome 
aberrations from peripheral blood samples is the most reliable method to evaluate real 
or suspect individual exposure to ionizing radiation. The recommended methods for 
biological dosimetry may provide a baseline for investigation of chromosomal fragility 
using ionizing radiation as clastogenic agent.
In this context, this work was designed to evaluate the feasibility of a new approach 
for chromosomal fragility test towards the diagnosis of Fanconi Anemia, replacing 
DEB/MMC by ionizing radiation as a clastogenic agent, following the guidelines of the 
International Atomic Energy Agency14 as for biological dosimetry.
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2 MATERIAL AND METHODS
2.1 STUDY POPULATION AND ETHICAL ASPECTS
The present study was conducted with two groups: 14 DEB-sensitive patients 
diagnosed with Fanconi anemia, and 14 healthy individuals with a negative DEB test 
(control), aged from 6 to 18-year-old (mean age 11.5 years). None of them underwent 
medical procedures involving IR or mutagenic chemicals, at least three months before this 
study. This research complied with the Declaration of Helsinki and was performed following 
recommendations of the Committee of Ethics in Research involving Humans at the Health 
Sciences Center of the Federal University of Pernambuco (nº 196555). All children’s parents 
were informed about the purpose of this study, after which written consent was provided. 
2.2 BLOOD SAMPLES AND IRRADIATION SETUP
From each volunteer, a sample was obtained by venipuncture in heparinized tubes. 
The total sample was divided into two aliquots: one was kept as control (non-irradiated), 
while the other one was irradiated and analyzed based on the patented methodology 
for scoring unstable chromosomal aberrations in lymphocyte (Deposit nº BR10 2013 
0256684). The irradiation consisted of X-rays from a 6 MV linear accelerator (Siemens, 
Primus, USA) at a dose rate of 2 Gy.min.1 Syringes (3 mL) were positioned in a solid water-
equivalent phantom (ρ = 0.99 g.cm-3), which simulated soft tissues of the human body. 
The blood samples were placed in the center of a 15x15 cm radiation field at a source-
sample distance of 0.80 m from the radiation source at the phantom, as shown in Figure 
1, and received 2 Gy.
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Figure 1 – Setup of blood sample irradiation
After irradiation, the sample was kept at 37 °C in a water bath for 2 hours, before 
setting up lymphocyte cultures. For each culture, 0.4 mL of whole blood was added to 
4 mL RPMI 1640 medium supplemented with 0.5 mL fetal calf serum (Cultilab, Brazil), 
and 0.1 mL phytohemagglutinin (Gibco, Brazil). The cultures were incubated at 37 °C in 
humidified air with 5% CO2 for 48 h. These procedures were consistent with the guidelines 
of the International Atomic Energy Agency manual.14 
2.3 SLIDE PREPARATION AND CA SCORING 
The slides were prepared as described by Henegariu and coworkers,15 with some 
modifications. Metaphase spreads were stained with 5% Giemsa solution and air-dried. 
For chromosomal aberration scoring, 200 complete metaphase cells were counted per 
sample. In addition to dicentrics, three other groups of chromosomal aberrations were also 
considered: breakage and failures; fragments; radial configurations. Slides from each culture 
were analyzed through conventional light microscopes (Leica DME 13595, Germany). 
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2.4 STATISTICAL ANALYSES
The t-test (for small samples, at the significant level of 5%) was employed to 
establish the confidence intervals of the frequencies of chromosomal aberrations.
3 RESULTS
Figure 2 points out a typical chromosomal radial formation (arrow), a kind of 
chromosomal aberration that is not found in metaphases cells in samples of healthy 
individuals. 
Figure 2 – Metaphase presenting a radial formation (arrow)
Table 1 resumes confidence interval obtained for the frequencies of chromosomal 
aberrations using t-student distribution in small samples, for normal and DEB-sensitive 
(FA) subjects.
......................................................................................................................Original Research - A new methodology for...
195Archives in Biosciences & Health,  v. 1, i. 2, p. 189-200, jul./dec. 2019
Table 1 – Confidence intervals (t-Student, α = 0.05) of the frequency of chromosomal aberration (CA) for 
each study group
Chromosomal Aberrations
Confidence intervals of CA (%)
Normal FA subjects (*)
Dicentrics 14.4 – 18.3 6.1 – 13.3
Breakage and failures  1.1 –   2.7 9.4 – 20.4
Fragments 6.0 – 11.2 11.8 – 16.1
Radial formations not found 2.0 – 8.3
Note: (*) DEB sensitive.
4 DISCUSSION 
According to Table 1, and compared to healthy subjects, the results for DEB-
sensitive individuals reveal a decrease of dicentrics and a rise of breakage, fragments, and 
complex chromosomal figures. This pattern of distribution for FA patients was already 
expected. The irradiation process results in several DNA damages, where double-strand 
breaks (DSBs) are the most serious ones.  
In normal cells, homologous recombination (HR) and non-homologous end-
joining (NHEJ) are the two major recombination pathways to DNA repair.9 HR acts in the 
late S and G2 phases, while the DNA-repair by NHEJ is predominant in the remaining 
phase of the cell cycle.9 Thus, failures in the HR and NHEJ mechanisms, which identify and 
attempt to repair radioinduced DNA-damage, will reflect in a decrease in the frequency of 
dicentrics, followed by an increase in the number of other chromosomal alterations, with, 
eventually, the formation of more complex structures as well, such as radial chromosomes 
(also referred as tri-radial, quadri-radial, and rearrangements). 
Figure 2 presents a typical example of complex chromosomal aberration (radial 
formation). In this case, a tri-radial (indicated by an arrow in that figure). This kind of alteration 
is not commonly found in studies involving biological dosimetry from samples of normal 
subjects. The appearance of such complex chromosomal structures in metaphase slides is 
directly linked to the hypersensitivity of AF subjects to ionizing radiation and associated 
with genomic instability, which is responsible for chromosomal fragility. 
In biological dosimetry, dose-effect relationships obtained after in vitro irradiation 
of blood can be used as a calibration curve to estimate the absorbed dose from irradiation in 
vivo.14,16 Generally, frequencies of dicentrics are correlated to radiation doses, which depend 
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on radiation quality (or LET–Linear Energy Transfer) and relative biological effectiveness 
(RBE). However, in the assessment of absorbed doses from the same irradiated blood 
sample, interlaboratory variations are quite common. 
These variations arise from several reasons such as environmental conditions of 
each laboratory, choice of reagents, handling procedures and equipment, and the level of 
training for the subjective nature of microscopic identification of unstable chromosome 
alterations.17 Hence, the International Atomic Energy Agency recommends that each 
cytogenetic laboratory should generate its own dose-response curve in order to perform 
biodosimetry.14 Similarly to biological dosimetry assays, using the methodology here 
proposed for the diagnosis of FA by the irradiation of blood sample, there might be some 
interlaboratory fluctuations regarding confidence intervals of the chromosomal aberrations 
presented in this study. 
FA subjects present an extensive phenotypic variability and may also present 
severe degrees to mild in distinct patients. Patients presenting a mild clinical picture are 
classified as AF mosaic (with a 30% incidence of patients with AF) for carrying affected 
and unaffected cells in the same tissue. This occurs by spontaneous reversal of one of the 
mutated alleles in hematopoietic lymphocytes3,4,18. Naturally, further studies employing 
the methodology carried out here should be performed with different degrees of FA 
subjects, for evaluating their influence over the frequency of chromosomal aberrations.
Furthermore, to diagnose diseases associated with chromosomal fragility, current 
laboratory tests employ toxic chemical agents (DEB/MMC), which are potential carcinogens, 
and precautions should be taken when handling these compounds. Therefore, the use of 
these compounds has several restrictions on their acquisition, transport, manipulation, 
and disposal. However, the methodology proposed in this work uses standard safety 
procedures for sample irradiation, followed by well-known cell culture protocols for 
metaphase analyses of lymphocytes. As implemented in this study, blood samples of 
patients could be irradiated in a hospital RT department, and then sent to a cytogenetics 
laboratory. 
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5 CONCLUSION
This work, which is fundamentally based on the biological dosimetry knowledge, 
paves the way to an alternative, safe, and affordable methodology of a laboratory test for 
diagnosis of Fanconi anemia.
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